Catalyst Pharmaceuticals, Inc.

Florida US
NEWS
FDA
In the next two weeks, the FDA is scheduled to decide on four drug applications and hold two highly anticipated advisory committee meetings.
There were a lot of clinical trial announcements this week, driven by the European Society for Medical Oncology annual conference. Here’s a look.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Resubmission of NDA for Firdapse on schedule for end of the first quarter.
JOBS
IN THE PRESS